chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Red spot below injection site itching; Red spot below the injection site the size of a silver dollar; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Red spot below injection site itching) and VACCINATION SITE RASH (Red spot below the injection site the size of a silver dollar) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE RASH (Red spot below the injection site the size of a silver dollar). On 03-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Red spot below injection site itching). At the time of the report, VACCINATION SITE PRURITUS (Red spot below injection site itching) and VACCINATION SITE RASH (Red spot below the injection site the size of a silver dollar) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details was not provided. Treatment medications were not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow-up received and no new information.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Nausea, Tremor
Clinical narrative: Constant dizziness; Chills; Patient feels like she wants to throw up; Trembling inside; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Constant dizziness), CHILLS (Chills), NAUSEA (Patient feels like she wants to throw up) and TREMOR (Trembling inside) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included Blood Pressure Pill for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced DIZZINESS (Constant dizziness), CHILLS (Chills), NAUSEA (Patient feels like she wants to throw up) and TREMOR (Trembling inside). On 25-Jan-2021, DIZZINESS (Constant dizziness), CHILLS (Chills), NAUSEA (Patient feels like she wants to throw up) and TREMOR (Trembling inside) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included Blood Pressure Pill.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Nasopharyngitis
Clinical narrative: both glands were swollen and painful; sounded like she had bad cold; left gland was swollen from the jaw to the throat and the glands under her; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (sounded like she had bad cold), LYMPHADENOPATHY (left gland was swollen from the jaw to the throat and the glands under her) and LYMPHADENOPATHY (both glands were swollen and painful) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced NASOPHARYNGITIS (sounded like she had bad cold) and LYMPHADENOPATHY (left gland was swollen from the jaw to the throat and the glands under her). On 06-Feb-2021, the patient experienced LYMPHADENOPATHY (both glands were swollen and painful). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (sounded like she had bad cold), LYMPHADENOPATHY (left gland was swollen from the jaw to the throat and the glands under her) and LYMPHADENOPATHY (both glands were swollen and painful) outcome was unknown. Not Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Glucose tolerance impaired, Neck pain, X-ray
Clinical narrative: Neck hurt bad; Neck started bothering her; Arthritis in the neck; Pre-diabetic; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NECK PAIN (Neck started bothering her), ARTHRITIS (Arthritis in the neck), NECK PAIN (Neck hurt bad) and GLUCOSE TOLERANCE IMPAIRED (Pre-diabetic) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Pre-diabetic, Glaucoma, High cholesterol, Hypertension and Arthritis. Concomitant products included BIMATOPROST (LUMIGAN) for Glaucoma, PRAVASTATIN for High cholesterol, CHLORTHALIDONE for Hypertension, POTASSIUM for Potassium replacement.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced GLUCOSE TOLERANCE IMPAIRED (Pre-diabetic). On 05-Feb-2021, the patient experienced NECK PAIN (Neck started bothering her) and ARTHRITIS (Arthritis in the neck). On 08-Feb-2021, the patient experienced NECK PAIN (Neck hurt bad). The patient was treated with METHYLPREDNISOLONE (MEDROL DOSEPAK) at an unspecified dose and frequency. At the time of the report, NECK PAIN (Neck started bothering her), ARTHRITIS (Arthritis in the neck), NECK PAIN (Neck hurt bad) and GLUCOSE TOLERANCE IMPAIRED (Pre-diabetic) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: arthritis in the neck.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced MYALGIA (sore arm). At the time of the report, MYALGIA (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding, Vaccination site pain
Clinical narrative: Exposure of lactating female; left deltoid pain around vaccine administration site; This spontaneous case was reported by an other and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure of lactating female) and VACCINATION SITE PAIN (left deltoid pain around vaccine administration site) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure of lactating female) and VACCINATION SITE PAIN (left deltoid pain around vaccine administration site). At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure of lactating female) and VACCINATION SITE PAIN (left deltoid pain around vaccine administration site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Body temperature increased, Fatigue
Clinical narrative: she felt tired; weak; joint pain; back pain; fever; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (she felt tired), ASTHENIA (weak), ARTHRALGIA (joint pain), BACK PAIN (back pain) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 immunisation.     No medical history was provided by the reporter.     On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (she felt tired), ASTHENIA (weak), ARTHRALGIA (joint pain) and BACK PAIN (back pain). On an unknown date, the patient experienced PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FATIGUE (she felt tired), ASTHENIA (weak), ARTHRALGIA (joint pain), BACK PAIN (back pain) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, Body temperature increased: 101.6f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: she felt tired; weak; joint pain; back pain; fever; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (she felt tired), ASTHENIA (weak), ARTHRALGIA (joint pain), BACK PAIN (back pain) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 immunisation.     No medical history was provided by the reporter.     On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (she felt tired), ASTHENIA (weak), ARTHRALGIA (joint pain) and BACK PAIN (back pain). On an unknown date, the patient experienced PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FATIGUE (she felt tired), ASTHENIA (weak), ARTHRALGIA (joint pain), BACK PAIN (back pain) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, Body temperature increased: 101.6f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Headache, Nausea
Clinical narrative: Nausea; Fever; Chills; Bad headache; Joint aches; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Bad headache) and ARTHRALGIA (Joint aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced NAUSEA (Nausea), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Bad headache) and ARTHRALGIA (Joint aches). At the time of the report, NAUSEA (Nausea), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Bad headache) and ARTHRALGIA (Joint aches) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, Body temperature: 100.f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Nausea; Fever; Chills; Bad headache; Joint aches; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Bad headache) and ARTHRALGIA (Joint aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced NAUSEA (Nausea), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Bad headache) and ARTHRALGIA (Joint aches). At the time of the report, NAUSEA (Nausea), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Bad headache) and ARTHRALGIA (Joint aches) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, Body temperature: 100.f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Vaccination site pain
Clinical narrative: 'pain at the injection site; stomach ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN ('pain at the injection site) and ABDOMINAL PAIN UPPER (stomach ache) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN ('pain at the injection site) and ABDOMINAL PAIN UPPER (stomach ache). At the time of the report, VACCINATION SITE PAIN ('pain at the injection site) and ABDOMINAL PAIN UPPER (stomach ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Pyrexia
Clinical narrative: drop in blood pressure; fever; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE DECREASED (drop in blood pressure) and PYREXIA (fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced BLOOD PRESSURE DECREASED (drop in blood pressure) and PYREXIA (fever). At the time of the report, BLOOD PRESSURE DECREASED (drop in blood pressure) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Paraesthesia
Clinical narrative: shortness of breath; chest tightness; tingling in her hands; A spontaneous report was received from a Healthcare Professional concerning a 49-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events shortness of breath, chest tightness, tingling in her hands.  The patient's medical history was not provided. She had a history of blood transfusion many years ago to which she had a reaction. No relevant concomitant medications were reported.  On 30 Dec 2020, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 004M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 27 Jan 2021, 6 minutes after the administration of the vaccine, the patient experienced the events shortness of breath. chest tightness, tingling in her hands. The patient's blood pressure was 162/96, heart rate 63 per min, oxygen saturation 93-94%. The patient was noted to be alert and oriented. After another 6 minutes, the patient also complained of chest tightness and tingling in her hands. Blood glucose was 80. After 15 minutes, blood pressure- 160/92, heart rate 82/min and O2 - 100%. The patient was observed for around 40 minutes then was feeling fine and was sent home  Treatment details included Benadryl oral.  Action taken with mRNA-1273 in response to the events was not reported.   On 27 Jan 2021 the outcome of events , shortness of breath. chest tightness, tingling in her hands was resolved. .; Reporter's Comments: This case concerns a 49-year-old female with NS unexpected events of chest discomfort, dyspnea, paresthesia. Event onset occurred the same day as the second dose of mRNA-1273. Treated with Benadryl. Events resolved. Based on the current available information and temporal association between use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Vaccination site bruising, Vaccination site erythema
Clinical narrative: Little soreness on his arm; Little bit tired; Bruising where he got the shot; Redness below the shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little soreness on his arm), VACCINATION SITE BRUISING (Bruising where he got the shot), VACCINATION SITE ERYTHEMA (Redness below the shot) and FATIGUE (Little bit tired) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No relevant Medical history Reported.  Concomitant products included WARFARIN for an unknown indication.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE BRUISING (Bruising where he got the shot) and VACCINATION SITE ERYTHEMA (Redness below the shot). On an unknown date, the patient experienced PAIN IN EXTREMITY (Little soreness on his arm) and FATIGUE (Little bit tired). At the time of the report, PAIN IN EXTREMITY (Little soreness on his arm), VACCINATION SITE BRUISING (Bruising where he got the shot), VACCINATION SITE ERYTHEMA (Redness below the shot) and FATIGUE (Little bit tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Contain no new information.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash
Clinical narrative: small rash; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of RASH (small rash) and HEADACHE (Headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (small rash) and HEADACHE (Headaches). At the time of the report, RASH (small rash) and HEADACHE (Headaches) outcome was unknown. Not Provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Myalgia
Clinical narrative: flu like symptoms; aching body; chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (aching body) and CHILLS (chills) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (aching body) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (aching body) and CHILLS (chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by the reporter.   No treatment information for the events was provided.   This case was linked to MOD-2021-221315, MOD-2021-221315 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021: event outcome updated, patient reported she received second dose of the vaccine and experienced same adverse events. The events after both doses resolved in 1.5 to 2 days. she reported she is fine now. New case created for second dose.
Sex: F
Vaccine: COVID19
Symptoms: Asthenopia, Eye pain, Eye swelling, Fatigue, Pain in extremity
Clinical narrative: eyes swollen/eyes were swelling and lowered.; arm a little sore; eyes were tired/field of vision was not normal; sore; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (eyes swollen/eyes were swelling and lowered.), PAIN IN EXTREMITY (arm a little sore), ASTHENOPIA (eyes were tired/field of vision was not normal), EYE PAIN (sore) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Osteopenia (The patient receives a shot for osteopenia every 6 month.). Concurrent medical conditions included Dust allergy, Allergy to molds, Pollen allergy, Allergy to animal (allergic to cats), Allergy to antibiotic (Allergic to Zipol and Lagil.), Grass allergy (grass and trees allergy) and Drug allergy (codeine). Concomitant products included GLUCOSAMINE for Joint ache, TRANEXAMIC ACID (NEXIM), MULTIVITAMIN & MINERAL, TOCOPHERYL ACETATE (VITAMIN E-400) and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 22-Jan-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE SWELLING (eyes swollen/eyes were swelling and lowered.), PAIN IN EXTREMITY (arm a little sore), ASTHENOPIA (eyes were tired/field of vision was not normal), EYE PAIN (sore) and FATIGUE (fatigue). At the time of the report, EYE SWELLING (eyes swollen/eyes were swelling and lowered.), PAIN IN EXTREMITY (arm a little sore), ASTHENOPIA (eyes were tired/field of vision was not normal), EYE PAIN (sore) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding
Clinical narrative: Received the vaccine and is currently breast feeding; A spontaneous report was received from a Healthcare Professional concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was currently breast feeding.   The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: Batch number not provided) ifor prophylaxis of COVID-19 infection.experienced the event someone who has received the vaccine and is currently breast feeding.   No treatment information was provided. No relevant laboratory details were included.  Action taken with mRNA-1273 in response to the events was not reported.   Outcome of the events was resolved.; Sender's Comments: This is a case of product exposure during breastfeeding with no associated AEs. Patient will continue to be contacted for further monitoring of AEs.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: vaccination adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (vaccination adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (vaccination adverse reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: Terrible headache; Nausea; Fever of 101F; No appetite; Chills; Felt so bad I went to bed early; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Terrible headache), NAUSEA (Nausea), PYREXIA (Fever of 101F), DECREASED APPETITE (No appetite) and CHILLS (Chills) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O1112OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Colitis. Concomitant products included MESALAZINE (LIALDA) for For colitis, CLONAZEPAM, MULTIVITAMIN & MINERAL and SIMVASTATIN for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced HEADACHE (Terrible headache), NAUSEA (Nausea), PYREXIA (Fever of 101F), DECREASED APPETITE (No appetite), CHILLS (Chills) and FATIGUE (Felt so bad I went to bed early). On 19-Jan-2021, HEADACHE (Terrible headache), NAUSEA (Nausea), PYREXIA (Fever of 101F), DECREASED APPETITE (No appetite), CHILLS (Chills) and FATIGUE (Felt so bad I went to bed early) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Body temperature: 101f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Terrible headache; Nausea; Fever of 101F; No appetite; Chills; Felt so bad I went to bed early; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Terrible headache), NAUSEA (Nausea), PYREXIA (Fever of 101F), DECREASED APPETITE (No appetite) and CHILLS (Chills) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O1112OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Colitis. Concomitant products included MESALAZINE (LIALDA) for For colitis, CLONAZEPAM, MULTIVITAMIN & MINERAL and SIMVASTATIN for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced HEADACHE (Terrible headache), NAUSEA (Nausea), PYREXIA (Fever of 101F), DECREASED APPETITE (No appetite), CHILLS (Chills) and FATIGUE (Felt so bad I went to bed early). On 19-Jan-2021, HEADACHE (Terrible headache), NAUSEA (Nausea), PYREXIA (Fever of 101F), DECREASED APPETITE (No appetite), CHILLS (Chills) and FATIGUE (Felt so bad I went to bed early) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Body temperature: 101f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Injection site reaction, Injection site warmth, Skin reaction, Vaccination site rash
Clinical narrative: Raised bumps; Warm; Oval Pattern at injection site; vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of SKIN REACTION (Raised bumps), INJECTION SITE WARMTH (Warm), INJECTION SITE REACTION (Oval Pattern at injection site) and VACCINATION SITE RASH (vaccination site rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN REACTION (Raised bumps), INJECTION SITE WARMTH (Warm), INJECTION SITE REACTION (Oval Pattern at injection site) and VACCINATION SITE RASH (vaccination site rash). At the time of the report, SKIN REACTION (Raised bumps), INJECTION SITE WARMTH (Warm), INJECTION SITE REACTION (Oval Pattern at injection site) and VACCINATION SITE RASH (vaccination site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Additional information received through TCR. Added patient email
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Headache ever since I took the shot/had needles poking in the top of my head; Arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache ever since I took the shot/had needles poking in the top of my head) and PAIN IN EXTREMITY (Arm is sore) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Myopathy and Heart valve regurgitation (The patient had two leaky valves in her heart).    On 03-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced HEADACHE (Headache ever since I took the shot/had needles poking in the top of my head) and PAIN IN EXTREMITY (Arm is sore). At the time of the report, HEADACHE (Headache ever since I took the shot/had needles poking in the top of my head) and PAIN IN EXTREMITY (Arm is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site is hot to touch; Injection site is red; Injection site is itchy; Injection site is swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site is hot to touch), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE SWELLING (Injection site is swollen) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Injection site is hot to touch), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE SWELLING (Injection site is swollen). At the time of the report, VACCINATION SITE WARMTH (Injection site is hot to touch), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE SWELLING (Injection site is swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be exclude
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersomnia, Vaccination site pain
Clinical narrative: Left arm soreness; He slept for about 8 hrs during those 2 days, usually he sleeps for just 5-6 hrs.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm soreness) and HYPERSOMNIA (He slept for about 8 hrs during those 2 days, usually he sleeps for just 5-6 hrs.) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (Left arm soreness) and HYPERSOMNIA (He slept for about 8 hrs during those 2 days, usually he sleeps for just 5-6 hrs.). On 04-Feb-2021, VACCINATION SITE PAIN (Left arm soreness) had resolved. At the time of the report, HYPERSOMNIA (He slept for about 8 hrs during those 2 days, usually he sleeps for just 5-6 hrs.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: developed COVID; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (developed COVID) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (developed COVID). At the time of the report, COVID-19 (developed COVID) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered COVID-19 (developed COVID) to be not applicable.    No Concomitant and  treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Significant follow up appended :- AE update On 14-Jul-2021: Non-Significant Follow Up- (Reporter updated as Pharmacist and HCP as yes)
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Decreased appetite, Fatigue, Hypertension, Myalgia
Clinical narrative: loss of appetite; blood pressure was high; experienced symptoms of COVID-19; achy hurting body; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (experienced symptoms of COVID-19), MYALGIA (achy hurting body), FATIGUE (fatigue), DECREASED APPETITE (loss of appetite) and HYPERTENSION (blood pressure was high) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included METFORMIN for Diabetes mellitus.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced COVID-19 (experienced symptoms of COVID-19), MYALGIA (achy hurting body), FATIGUE (fatigue) and HYPERTENSION (blood pressure was high). On an unknown date, the patient experienced DECREASED APPETITE (loss of appetite). On 29-Jan-2021, COVID-19 (experienced symptoms of COVID-19), MYALGIA (achy hurting body), FATIGUE (fatigue) and DECREASED APPETITE (loss of appetite) had resolved. At the time of the report, HYPERTENSION (blood pressure was high) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: loss of appetite; blood pressure was high; experienced symptoms of COVID-19; achy hurting body; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (experienced symptoms of COVID-19), MYALGIA (achy hurting body), FATIGUE (fatigue), DECREASED APPETITE (loss of appetite) and HYPERTENSION (blood pressure was high) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included METFORMIN for Diabetes mellitus.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced COVID-19 (experienced symptoms of COVID-19), MYALGIA (achy hurting body), FATIGUE (fatigue) and HYPERTENSION (blood pressure was high). On an unknown date, the patient experienced DECREASED APPETITE (loss of appetite). On 29-Jan-2021, COVID-19 (experienced symptoms of COVID-19), MYALGIA (achy hurting body), FATIGUE (fatigue) and DECREASED APPETITE (loss of appetite) had resolved. At the time of the report, HYPERTENSION (blood pressure was high) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hypoaesthesia, Pyrexia
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of HYPOAESTHESIA (numbness on both hands), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HYPOAESTHESIA (numbness on both hands), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills). On 06-Feb-2021, PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) had resolved. At the time of the report, HYPOAESTHESIA (numbness on both hands) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary web syndrome, Limb discomfort, Neck mass, Neck pain
Clinical narrative: Lymphatic cording,cord pops up and protrudes out of arm; Cant raise arm; Swollen identifiable area in the clavicle area; Sore neck caused by lymph node at the clavicle region; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY WEB SYNDROME (Lymphatic cording,cord pops up and protrudes out of arm), LIMB DISCOMFORT (Cant raise arm), NECK PAIN (Sore neck caused by lymph node at the clavicle region) and NECK MASS (Swollen identifiable area in the clavicle area) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced NECK PAIN (Sore neck caused by lymph node at the clavicle region). On an unknown date, the patient experienced AXILLARY WEB SYNDROME (Lymphatic cording,cord pops up and protrudes out of arm), LIMB DISCOMFORT (Cant raise arm) and NECK MASS (Swollen identifiable area in the clavicle area). On 20-Jan-2021, NECK PAIN (Sore neck caused by lymph node at the clavicle region) had resolved. At the time of the report, AXILLARY WEB SYNDROME (Lymphatic cording,cord pops up and protrudes out of arm), LIMB DISCOMFORT (Cant raise arm) and NECK MASS (Swollen identifiable area in the clavicle area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: injection site is "pink"; swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site is "pink") and VACCINATION SITE SWELLING (swollen) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site is "pink") and VACCINATION SITE SWELLING (swollen). At the time of the report, VACCINATION SITE ERYTHEMA (injection site is "pink") and VACCINATION SITE SWELLING (swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Patient had not taken any treatment medications for the events.
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Vaccination site warmth
Clinical narrative: Red, blotchy area that's warm to the touch; Red, blotchy area that's warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red, blotchy area that's warm to the touch) and VACCINATION SITE WARMTH (Red, blotchy area that's warm to the touch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Red, blotchy area that's warm to the touch) and VACCINATION SITE WARMTH (Red, blotchy area that's warm to the touch). At the time of the report, RASH ERYTHEMATOUS (Red, blotchy area that's warm to the touch) and VACCINATION SITE WARMTH (Red, blotchy area that's warm to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Rash
Clinical narrative: Red; Itchy; Patch; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red), INJECTION SITE PRURITUS (Itchy) and RASH (Patch) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Red), INJECTION SITE PRURITUS (Itchy) and RASH (Patch). At the time of the report, INJECTION SITE ERYTHEMA (Red), INJECTION SITE PRURITUS (Itchy) and RASH (Patch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment included Benadryl gel, Antihistamine
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Swelling
Clinical narrative: A circular red patch, a little itchy, little swelling; A circular red patch, a little itchy, little swelling; A circular red patch, a little itchy, little swelling; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (A circular red patch, a little itchy, little swelling), RASH PRURITIC (A circular red patch, a little itchy, little swelling) and RASH (A circular red patch, a little itchy, little swelling) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01262CA) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced SWELLING (A circular red patch, a little itchy, little swelling), RASH PRURITIC (A circular red patch, a little itchy, little swelling) and RASH (A circular red patch, a little itchy, little swelling). On 08-Feb-2021, SWELLING (A circular red patch, a little itchy, little swelling), RASH PRURITIC (A circular red patch, a little itchy, little swelling) and RASH (A circular red patch, a little itchy, little swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.